Fib to Alb Ratio in Type 2 Dkd
NCT05691985 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-01-17
Summary
Aimed to investigate the association of fibrinogen to albumin ratio (FAR) with DKD type 2 and to prove its possible role as a novel biomarker to predict and prevent DKD progression.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Essam Abdelmonem Sadek, Prof · Assiut University
-
Mohamed Hassan Mustafa, Dr · Assiut University
-
Abdallah Gamal Abd El Hafeez, Resident · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-31
- Primary Completion
- 2024-03-31
- Completion
- 2025-02-28
More Related Trials
-
Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in Pakistan
NCT02444845 ·Status: COMPLETED
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
Prevention of Renal Failure in People Followed for Type 2 Diabetes in General Practice
NCT05749679 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients with Type 2 Diabetes and CKD
NCT06820567 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Predicting Response to Incretin Based Agents in Type 2 Diabetes
NCT01503112 ·Status: COMPLETED
-
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
NCT06954090 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe
NCT04589351 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy
NCT07173686 ·Status: NOT_YET_RECRUITING
-
Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
NCT05469659 ·Status: RECRUITING ·Phase: PHASE2
-
The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure
NCT01937858 ·Status: TERMINATED
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Fenofibrate Therapy in Diabetic Nephropathy
NCT03869931 ·Status: UNKNOWN ·Phase: PHASE3
-
T-regulatory Cells in Diabetic Type Two Nephropathy
NCT03591939 ·Status: UNKNOWN
-
NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels
NCT00279084 ·Status: UNKNOWN ·Phase: NA
-
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
NCT05849220 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
NCT06528405 ·Status: RECRUITING ·Phase: PHASE2
-
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
NCT05897372 ·Status: TERMINATED ·Phase: PHASE2
-
Renal Impairment in Type 2 Diabetic Subjects
NCT00554450 ·Status: COMPLETED ·Phase: PHASE1
-
Anemia-Related Outcomes in Patients With CKD Treated With Dapagliflozin
NCT06813222 ·Status: ACTIVE_NOT_RECRUITING
-
The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
NCT06049550 ·Status: UNKNOWN
-
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
NCT02911792 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)
NCT00708981 ·Status: COMPLETED ·Phase: NA
-
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
NCT04498156 ·Status: COMPLETED
-
Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study
NCT02848508 ·Status: WITHDRAWN ·Phase: PHASE2
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
NCT00342927 ·Status: ACTIVE_NOT_RECRUITING